Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin
International Journal of Molecular Sciences · 07.01.2023 · 24 (2) · 1203
DOI: 10.3390/ijms24021203 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.01.2023. Verfasst von Ivana Palucci und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Sciences and Infectious Diseases, Fondazione Policlinico Universitario "A. Gemelli", 00168 Rome, Italy. Hauptthemen laut MEDLINE: Mycobacterium abscessus, Mycobacterium Infections, Nontuberculous. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RICERCA FINALIZZATA 2018, Fondazione Fibrosi Cistica, National Institute for Infectious Diseases IRCCS 'Lazzaro Spallanzani'.
Abstract (Originalsprache)
Host-directed therapies are emerging as a promising tool in the curing of difficult-to-treat infections, such as those caused by drug-resistant bacteria. In this study, we aim to test the potential activity of the FDA- and EMA-approved drugs cysteamine and cystamine against Mycobacterium abscessus. In human macrophages (differentiated THP-1 cells), these drugs restricted M. abscessus growth similar to that achieved by amikacin. Here, we use the human ex vivo granuloma-like structures (GLS) model of infection with the M. abscessus rough (MAB-R) and smooth (MAB-S) variants to study the activity of new therapies against M. abscessus. We demonstrate that cysteamine and cystamine show a decrease in the number of total GLSs per well in the MAB-S and MAB-R infected human peripheral blood mononuclear cells (PBMCs). Furthermore, combined administration of cysteamine or cystamine with amikacin resulted in enhanced activity against the two M. abscessus morpho variants compared to treatment with amikacin only. Treatment with cysteamine and cystamine was more effective in reducing GLS size and bacterial load during MAB-S infection compared with MAB-R infection. Moreover, treatment with these two drugs drastically quenched the exuberant proinflammatory response triggered by the MAB-R variant. These findings showing the activity of cysteamine and cystamine against the R and S M. abscessus morphotypes support the use of these drugs as novel host-directed therapies against M. abscessus infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Sciences and Infectious Diseases, Fondazione Policlinico Universitario "A. Gemelli", 00168 Rome, Italy.
- Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie-Sezione di Microbiologia, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
- Dipartimento di Biologia, Università degli Studi di Roma "Tor Vergata", 00173 Rome, Italy.
- Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases Translational Research Unit, IRCCS 'Lazzaro Spallanzani', 00149 Rome, Italy.
- Mater Olbia Hospital, 07026 Olbia, Italy.
ORCID-Profile: Ivana Palucci, Flavio De Maio, Luca Occhigrossi, Federica Rossin, Delia Goletti, Maurizio Sanguinetti
Förderung
- RICERCA FINALIZZATA 2018
- Fondazione Fibrosi Cistica
- National Institute for Infectious Diseases IRCCS 'Lazzaro Spallanzani'
- Italian Ministry of Health
- National Institute for Infectious Diseases IRCCS ‘Lazzaro Spallanzani’
- Italian Ministry of Health, Ricerca Corrente
Zitieren
APA
Palucci, I., Salustri, A., De Maio, F., Pereyra Boza, M. D. C., Paglione, F., Sali, M., Occhigrossi, L., D'Eletto, M., Rossin, F., Goletti, D., Sanguinetti, M., Piacentini, M., & Delogu, G. (2023). Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin. International Journal of Molecular Sciences, 24(2), 1203. https://doi.org/10.3390/ijms24021203
Vancouver
Palucci I, Salustri A, De Maio F, Pereyra Boza MDC, Paglione F, Sali M, et al. Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin. International Journal of Molecular Sciences. 2023;24(2):1203. doi:10.3390/ijms24021203
BibTeX
@article{Palucci2023,
author = {Palucci, Ivana and Salustri, Alessandro and De Maio, Flavio and Pereyra Boza, Maria Del Carmen and Paglione, Francesco and Sali, Michela and Occhigrossi, Luca and D'Eletto, Manuela and Rossin, Federica and Goletti, Delia and Sanguinetti, Maurizio and Piacentini, Mauro and Delogu, Giovanni},
title = {Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {2},
pages = {1203},
doi = {10.3390/ijms24021203}
}
EUVIMED